[A monocentric retrospective study of low-dose rituximab in the treatment of 12 cases refractory or relapsed idiopathic autoimmune hemolytic anemia patients]

Zhonghua Xue Ye Xue Za Zhi. 2017 Dec 14;38(12):1075-1077. doi: 10.3760/cma.j.issn.0253-2727.2017.12.016.

[Article in Chinese]

Authors

Q Y Gao, C X Liu, Y Li, G X Peng, J P Li, Y Li, L Ye, H H Fan, L Song, L Zhang, L P Jing, K Zhou, X Zhao, W R Yang, Z J Wu, Y Yang, Y Z Xiong, F K Zhang¹

Affiliation

¹ Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin 300020, China.

PMID: 29365406
PMCID: PMC7342200
DOI: 10.3760/cma.j.issn.0253-2727.2017.12.016

No abstract available